发明名称 (+) naloxone and epinephrine combination therapy
摘要 A composition formulated for dose-wise delivery to a breathing passageway of a human, the composition comprising a carrier solution containing (+)naloxone and a pharmacologically effective amount of at least one adrenergic agonist, the (+)naloxone and agonist forming a mixture in the carrier. The at least one adrenergic agonist is selected from the group consisting of epinephrine, isoproterenol, albuterol, aminophylline, beclomethasone, dyphylline, flunisolide, isoetharine, metaproterenol, oxtriphylline, terbutaline, theophylline, pseudoephedrine, phenylephrine, ephedrine and norepinephrine. That composition is delivered by an atomizer means such as a liquid sprayer or inhaler to treat nasal congestion and asthmatic attacks. Further provided by the invention is a cardiovascular and respiratory stimulating composition for administration to a patient in doses, the composition comprising a pharmacologically effective concentration of (+)naloxone in a carrier solution. If necessary, the composition may also contain a pharmacologically effective amount of at least one adrenergic agonist.
申请公布号 AU5312601(A) 申请公布日期 2001.11.12
申请号 AU20010053126 申请日期 2001.04.03
申请人 SURE MEDICAL, INC. 发明人 JAMES L. CAFFREY
分类号 A61K9/00;A61K31/135;A61K31/44;A61K31/52 主分类号 A61K9/00
代理机构 代理人
主权项
地址